Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 5, 2012, Pages 458-465

  Lokke, Anders ^a   Ulrik, Charlotte Suppli ^b   Dahl, Ronald ^a   Plauborg, Liane ^c   Dollerup, Jens ^d   Kristiansen, Luise Cederkvist ^e   Cording, Patrick Hagge ^e   Dehlendorff, Christian ^e  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d PFIZER INC   (United States)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Airway obstruction; COPD; Early case finding; General practice; Spirometry

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; SALBUTAMOL;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; GENERAL PRACTICE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPIROMETRY; SPUTUM; SYMPTOM; WHEEZING;

ADULT; AGED; AGED, 80 AND OVER; DYSPNEA; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 84867038027     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.685118     Document Type: Article

References (32)

1. Celli BR, McNee W, ATS/ERS committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management and Prevention of COPD. Guidelines available from the GOLD website www. goldcopd.com (accessed October 2011).
3. Editors, Lancet. COPD - more than just tobacco smoke (editorial). Lancet 2009; 374:663.
4. Blanc PD, Menezes AM, Plane E, Mannino DM, Hallal PC, Toren K, Eisner MD, Zock JP. Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J 2009; 33:298-304.
5. Celli BR. Chronic obstructive pulmonary disease: from unjustifi ed nihilism to evidence-based optimism. Proc Am Th orac Soc 2006; 3:58-65.
6. Ferguson GT. Maintenance pharmacotherapy of mild and moderate COPD: What is the evidence? Respir Med 2011; 105:1268-1274.
7. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-tomoderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161:381-390.
8. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP for the UPLIFT investigators. Eff ect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecifi ed subgroup analysis of a randomised controlled trial. Lancet 2009; 374:1171-1178.
9. Bednarek M, Gorecka D, Wielgomas J et al. Smokers with airway obstruction are more likely to quit smoking. Th orax 2006; 61:869-873.
10. Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care 2006; 24:133-139.
11. KOL: Anbefalinger for tidlig opsporing, opfølgning, behandling, og rehabilitering (COPD: Recommendations for early detection, monitoring, treatment and rehabilitation; in Copenhagen Danish). Danish National Board of Health 2007.
12. Nielsen LM, Brorson S, Gorlen T, Jakobsen M, Lange P, Heebøll-Nielsen NC, Pallesen R, Smith M. KOL i Almen Praksis (COPD in General Practice; in Copenhagen Danish). Danish College of General Practitioners 2008.
13. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care. Prim Care Resp J 2006; 15:20-34.
14. Madsen F, Maltbæk N, Mortensen J, Pedersen OF. Lungefunktionsstandard (in Danish). Danish Society of Respiratory Medicine 2007; available from www.lungemedicin. dk (accessed October 2011).
15. Bestall JC, Paul EA, Garrod R, Granham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Th orax 1999; 54:581-586.
16. Quanjer PH, Tammeling GJ. Summary of recommendations. Standardized lung function testing. Report Working Party, European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19(suppl 5):7-20.
17. Pellegrin R, Viegi G, Brisasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968.
18. Ihaka I, Gentleman RR. A language for data analysis and graphics. J Computational Graphical Statistics 1996; 5:299-314.
19. EFPIA code on the promotion of prescription-only medicines to, and interactions with, healthcare professionals. European Federation of Pharmaceutical Industries and Associations (Council Directive 2001/83/EC). www.efpia.eu [last accessed 10.11]
20. Lægemiddelindustriforeningen www.lifdk.dk [last accessed10.11].
21. Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, Gogou E, Gourgoulianis KI, Kostikas K. COPD prevalence and the diff erences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J 2010; 19:363-70.
22. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative sample. Th orax 2006; 61:1043-1047.
23. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Th orax 2008; 63:402-407.
24. Stratelis G, Jacobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004; 54:201- 206.
25. Vanvoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: a case fi nding study in general practice. Respir Med 2007; 101:525-530.
26. Buff els J, Degryse J, Heyman J, Decramer M. Offi ce spirometry signifi cantly improves early detection of COPD in general practice: the DIDASCO study. Chest 2004; 125:1394-1399.
27. Price D, Freeman D, Cleland J, Kaplan A, Cerasoli F. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J 2011; 20:15-22.
28. Vollmer WM, Gislason T, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34:588-597.
29. Miller MR, Pedersen OF, Pellegrino R, Brusasco V. Debating the defi nition of airfl ow obstruction: time to move on? Eur Respir J 2009; 34:527-528.
30. Hvidsten SC, Storesund L, Wentzel-Klarse T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J 2010; 4:13-21.
31. Price D, Crockett A, Arne M, et al. Spirometry in primary care case-identifi cation, diagnosis and management of COPD. Prim Care Respir J 2009; 18:216-223.
32. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005; 127:1560-1564.